Corporate News


George Clinical China is headquartered in Beijing, where we are co-located with our parent organization, The George Institute. From this location, we oversee our operations throughout China which includes an office in Shanghai and a number of home based personnel. With China fast becoming the second largest pharmaceutical market in the world, along with its […]

Read More

May 26th, 2014


George Clinical is an Australian owned organization headquartered in Sydney, Australia. In Sydney, we are co-located with our parent organization, The George Institute, a world leading medical research institute. From this location, we oversee our operations throughout Asia-Pacific. Australia is an attractive place to conduct clinical research with an efficient regulatory process, highly experienced research […]

Read More

May 26th, 2014

The George Institute Annual Report 2013

We had a great year at The George Institute for Global Health in 2012-2013. This annual report outlines our continued focus on the need for Big Change in healthcare delivery around the world

Read More

April 1st, 2014

See you at ACC.14

From March 29th to 31st, the annual scientific congress for the American College of Cardiology (ACC) will be held at Washington, DC. Thought leaders congregate to discuss prevention, diagnosis and treatment of cardiovascular disease. This year, George Clinical will be represented by Professor Bruce Neal and Professor Henry Krum. See you there!

Read More

March 26th, 2014
Red paper lanterns

Happy Lunar New Year

George Clinical in China would like to wish all of our clients, sponsors and investigators the best wishes for Lunar New Year.

Read More

February 3rd, 2014

CBI’s Risk-Based Monitoring in Clinical Studies conference – a perspective from George Clinical

It is an exciting time as risk-based monitoring (RBM) application grows throughout industry.

Read More

November 20th, 2013

R&D tax incentives for George Clinical services

There’s no better time to be working with us. The Australian Tax Office will provide a tax incentive to encourage R&D activities in Australia, jointly administered by AusIndustry. Companies with < $20m per annum turnover can be eligible for 45% refundable tax offset; and other companies can be eligible for a non-refundable 40% tax offset. […]

Read More

August 28th, 2013

Data Management – People and Platforms

The George Clinical Data Management group offers end to end Data Management services for phase I – IV and post-marketing clinical trials, as well as tailored services for academic research trials.  Our goal is to provide flexible solutions for our customers and we offer a range of database options to suit study requirements. Fully validated […]

Read More

August 7th, 2013

George Clinical expands in the Asian region

In order to meet the growing needs of our customers, George Clinical has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second George Clinical office in India in Bengaluru to complement our head office in Hyderabad. With many of our large outcomes studies recruiting patients in India there is […]

Read More

April 16th, 2013
Beijing skyline

Appointment of industry leader to George Clinical China

George Clinical China has appointed a new General Manager to lead its growing operation in China as it seeks to provide a stronger platform for delivering clinical trials across the Asian region. A recognised healthcare professional, Philip Gregory has 25 years senior management experience in pharmaceutical, device and biotechnology industries. Prior to taking up the […]

Read More

December 4th, 2012
George Clinical

Profits from George Clinical support the work of The George Institute for Global Health.

Join our Mailing List

Add George Clinical to your network